¾¾µð³×Æ®¿÷½º, ¿§Áö ÄÄÇ»Æà Ç÷§Æû ¡®¿§Áö ¾ÖÇø®ÄÉÀ̼ǡ¯ Ãâ½Ã
¿Â¶óÀÎ ºñÁî´Ï½ºÀÇ ¹Îø¼º°ú È¿À²¼º ±Ø´ëÈ
(¼¿ï=´º½º¿ÍÀ̾î) 2024-09-03
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
The agreement builds on Organon¡¯s global product portfolio for conditions that impact women disproportionately. Women are three times more likely to experience migraine than men.[i]
(JERSEY CITY, N.J.=´º½º¿ÍÀ̾î) 2024-08-30
³×½½·¹ÄÚ¸®¾Æ, 2024 ¼¼°è û³âÀÇ ³¯ ¸Â¾Æ ³×½½·¹ÀÇ Ã»³â Áö¿ø È°µ¿ ¹× ¼º°ú °øÀ¯
¡®³×½½·¹ ´ÏÁî À¯½º(Nestl
(¼¿ï=´º½º¿ÍÀ̾î) 2024-08-13
ÃéÀå¾Ï ȯÀÚ¿ë Ç×¾Ï ¿µ¾ç º¸ÃæÁ¦ Nichi BRITE º£Å¸±Û·çÄ, ÀϺ» Ä¡Ä«¸ð¸®º´¿ø¿¡¼ °í¹«ÀûÀÎ ÀÓ»ó °á°ú º¸°í
(µµÄì=´º½º¿ÍÀ̾î) 2024-08-10
º£ÀÌÁø, 2024³â 2ºÐ±â À繫 ½ÇÀû ¹× ±â¾÷ ¾÷µ¥ÀÌÆ® ¹ßÇ¥¡¦ ±Û·Î¹ú ¼ºÀåÀÇ ´ÙÀ½ ´Ü°è ÁøÀÔ
ÃѼöÀÍ 9¾ï2900¸¸´Þ·¯·Î Àü³â µ¿±â ´ëºñ 56% Áõ°¡, GAAP ±âÁØ ¿µ¾÷ ¼Õ½Ç °¨¼Ò ¹× ºñ GAAP ±âÁØ ¿µ¾÷ÀÌÀÍ ´Þ¼º ±Û·Î¹ú ºê·çŲ»ç(BRUKINSA) ¼öÀÍ 6¾ï3700¸¸´Þ·¯·Î Àü³â µ¿±â ´ëºñ 107% Áõ°¡Çϸç Ç÷¾×ÇÐ ¸®´õ½Ê °È, BCL2 ¾ïÁ¦Á¦ ¼Õ·ÎÅäŬ¶ô½º(sonrotoclax)¿Í BTK Ç¥Àû ºÐÇØÁ¦(BTK-targeted degrader) BGB-16673¿¡ ´ëÇÑ Áß¿ä ÇÁ·Î±×·¥ÀÇ ÁøÀü ADC, ´ÙÁß Æ¯ÀÌÀû Ç×ü, Æó¾Ï, À¯¹æ¾Ï, À§Àå¾Ï¿¡ ´ëÇÑ Ç¥Àû Ä¡·áÁ¦¸¦ Æ÷ÇÔÇÑ 15°¡Áö ÀÌ»óÀÇ ¿¬±¸¿ë ºÐÀÚÀÇ Çõ½ÅÀûÀÎ °íÇü¾Ï ÆÄÀÌÇÁ¶óÀÎÀÇ ¹ßÀü ´ºÀúÁö¿¡ 8¾ï´Þ·¯, 42¿¡ÀÌÄ¿ ±Ô¸ðÀÇ Ç÷¡±×½Ê ¹Ì±¹ ¹ÙÀÌ¿À ÀǾàÇ° Á¦Á¶ ½Ã¼³ ¹× ÀÓ»ó R&D ¼¾Å͸¦ ¿°í, ¹ýÀÎ °üÇÒ±ÇÀ» ÄÉÀÌ¸Ç Á¦µµ¿¡¼ »ý¸í°úÇÐ ¸®´õ¿Í ±â°üÀ» À§ÇÑ Çõ½ÅÀûÀÎ »ý¸í°øÇÐ »ýÅ°èÀÎ ½ºÀ§½º·Î ÀÌÀüÇÒ °ÍÀ» Á¦¾ÈÇØ ±Û·Î¹ú ÀÔÁö¸¦ °È
(»÷ ¸¶Å׿À, Ķ¸®Æ÷´Ï¾Æ=´º½º¿ÍÀ̾î) 2024-08-10